2-Bromo-1-(4-methylsulfanylphenyl)ethanone

We are 2-Bromo-1-(4-methylsulfanylphenyl)ethanone CAS:42445-46-5 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Product Name: 2-Bromo-1-(4-methylsulfanylphenyl)ethanone
CAS No.: 42445-46-5
Synonym: 4-Methylthio-2'-bromoacetophenone
p-Methylthiophenacyl bromide
Formula: C9H9BrOS
MW: 245.14
Density: 1.49g/cm3
Boiling point: 330.7ºC at 760 mmHg
Flash point: 153.8ºC 
Refractive index: n20/D 1.606(lit.) 
 
Export Info
HS Code: 2930909099
UN No.: N.A
Hazard class: N.A
Packing level: N.A
 
Specification
Purity: ≥99.0%
Moisture: ≤0.20%
 
 
Application
Organic synthesis intermediate.
 
Packaging
250kg/barrel, can also be packaged according to customer requirements. 
 
Storage
Store in a cool, ventilated warehouse. 
Keep away from fire and heat. 
The temperature should not exceed 37 °C. 

2-Bromo-1-(4-methylsulfanylphenyl)ethanone


Related News: At the same time, through years of imitation and advanced technology learning, more and more domestic companies have participated in the field of highly original and characteristic APIs.(S, Z) -5-Amino-2- (dibencilamino) -1,6-difenilhex-4-en-3-ona CAS:156732-13-7 Beta Bionics is committed to obtaining regulatory approval and commercializing all three iLet configurations.[dimethylamino-(2,5-dioxopyrrolidin-1-yl)oxymethylidene]-dimethylazanium,hexafluorophosphate Beta Bionics is committed to obtaining regulatory approval and commercializing all three iLet configurations.4-Propoxyphenylboronic Acid The Company’s immuno-oncology product candidates include natural killer (NK) cell and T-cell cancer immunotherapies, which are designed to synergize with well-established cancer therapies, including immune checkpoint inhibitors and monoclonal antibodies, and to target tumor-associated antigens with chimeric antigen receptors (CARs).The Company’s immuno-oncology product candidates include natural killer (NK) cell and T-cell cancer immunotherapies, which are designed to synergize with well-established cancer therapies, including immune checkpoint inhibitors and monoclonal antibodies, and to target tumor-associated antigens with chimeric antigen receptors (CARs).

Related Products
Product Name
((3aR,4R,6aR)-6-methoxy-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl 4-methylbenzenesulfonate View Details
2,2-dimethyl-6-nitro-4H-pyrido[3,2-b][1,4]oxazin-3-one View Details
N-Isobutyl-3-nitroquinolin-4-amine View Details
2,4,5-Trichloropyrimidine manufacturer 3,3′,5,5′-Tetrabromo-1,1′-biphenyl Cas:16400-50-3 manufacturer 6-Chlorohex-1-ene manufacturer 7-Chloro-1H-indole-2-carboxylic acid manufacturer 2-Amino-5-methyl-3-thiophenecarbonitrile manufacturer